Histone methyltransferase DOT1L controls state-specific identity during B cell differentiation.

Area of Science:

• Immunology
• Epigenetics
• Molecular Biology

Background:

• B-cell differentiation into plasma cells involves epigenetic changes, but the precise mechanisms are not fully understood.
• Understanding B-cell fate regulation is critical for immune response and autoimmune disease research.

Purpose of the Study:

• To investigate the role of histone H3K79 methyltransferase DOT1L in B-cell differentiation.
• To elucidate the epigenetic mechanisms by which DOT1L controls B-cell fate and immune responses.

Main Methods:

• Utilized mouse models with Dot1L-deficient B cells.
• Performed in vitro differentiation assays with Dot1L deletion or chemical inhibition.
• Conducted combined epigenomics and transcriptomics analyses.

Main Results:

• Dot1L deficiency in B cells impaired germinal center formation and humoral immunity in vivo.
• In vitro, Dot1L deletion or inhibition led to aberrant B-cell differentiation and premature plasma cell characteristics.
• DOT1L was found to promote a pro-proliferative, germinal center program and indirectly support the repression of plasma cell differentiation programs.

Conclusions:

• DOT1L is a key epigenetic regulator of B-cell differentiation and immune responses.
• DOT1L establishes an epigenetic barrier essential for maintaining B-cell naivety and facilitating germinal center B-cell differentiation.